UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy

Epilepsia (Copenhagen), 2017-10, Vol.58 (10), p.1762-1770

2017

Volltextzugriff (PDF)

Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice

PloS one, 2014-05, Vol.9 (5), p.e96147-e96147

2014

Volltextzugriff (PDF)

PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases

Frontiers in endocrinology (Lausanne), 2022-12, Vol.13, p.1074911-1074911

2022

Volltextzugriff (PDF)

Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease

European journal of gastroenterology & hepatology, 2017-12, Vol.29 (12), p.1385-1388

2017

Volltextzugriff (PDF)

Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus: A rare case report and a review of the literature

Medicine (Baltimore), 2020-05, Vol.99 (21), p.e20390

2020

Volltextzugriff (PDF)

Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine

Behavioural brain research, 2014-11, Vol.274, p.390-399

2014

Volltextzugriff (PDF)

Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study

Cardiovascular diabetology, 2020-03, Vol.19 (1), p.28-9, Article 28

2020

Volltextzugriff (PDF)

Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice

International journal of molecular sciences, 2021-04, Vol.22 (7), p.3675

2021

Volltextzugriff (PDF)

Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC

Frontiers in cellular and infection microbiology, 2022-03, Vol.11, p.785166-785166

2022

Volltextzugriff (PDF)

Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs

PloS one, 2015-11, Vol.10 (11), p.e0142303

2015

Volltextzugriff (PDF)

Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice

Diabetes & metabolism journal, 2022-11, Vol.46 (6), p.829-842

2022

Volltextzugriff (PDF)

Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats

Journal of pharmacological sciences, 2015-03, Vol.127 (3), p.244-250

2015

Volltextzugriff (PDF)

PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease

Progress in neuro-psychopharmacology & biological psychiatry, 2014-08, Vol.53, p.35-44

2014

Volltextzugriff (PDF)

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients

Medicine (Baltimore), 2017-08, Vol.96 (31), p.e7671

2017

Volltextzugriff (PDF)

Efficacy of fenofibrate for diabetic retinopathy: A systematic review protocol

Medicine (Baltimore), 2019-04, Vol.98 (14), p.e14999

2019

Volltextzugriff (PDF)

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Scientific reports, 2021-09, Vol.11 (1), p.18708-18708, Article 18708

2021

Volltextzugriff (PDF)

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study

Current medical research and opinion, 2006-05, Vol.22 (5), p.873-883

2006

Volltextzugriff (PDF)

Function and mechanism of the human SOD2 gene in mice cerebral ischemia/ reperfusion injury

Acta Cirúrgica Brasileira, 2024-01, Vol.39, p.e393124

2024

Volltextzugriff (PDF)

Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives

Current medicinal chemistry, 2013-09, Vol.20 (26), p.3258-3266

2013

Volltextzugriff (PDF)

Efficacy and safety of coenzyme A versus fenofibrate in patients with hyperlipidemia: a multicenter, double-blind, double-mimic, randomized clinical trial

Current medical research and opinion, 2020-06, Vol.36 (6), p.941-945

2020

Volltextzugriff (PDF)

Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA

Revista española de enfermedades digestivas, 2018-09, Vol.110 (9), p.557-563

2018

Volltextzugriff (PDF)

Fenofibrate attenuates renal lipotoxicity in uninephrectomized mice with high-fat diet-induced obesity

Brazilian Journal of Nephrology, 2024-12, Vol.46 (4), p.e20230148

2024

Volltextzugriff (PDF)

Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report

BMC nephrology, 2024-05, Vol.25 (1), p.171-171, Article 171

2024

Volltextzugriff (PDF)

Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension

Journal of hypertension, 2013-04, Vol.31 (4), p.820-829

2013

Volltextzugriff (PDF)

Health-related quality of life amongst people diagnosed with abdominal aortic aneurysm and peripheral artery disease and the effect of fenofibrate

Scientific reports, 2020-09, Vol.10 (1), p.14583, Article 14583

2020

Volltextzugriff (PDF)

1 – 25 von 223

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(216)
Mit Volltextzugriff
(158)

Publikationsform

Artikel
(223)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(198)
Humans
(187)
Fenofibrate - Therapeutic Use
(183)
Life Sciences & Biomedicine
(183)
Male
(128)
Fenofibrate
(123)
Hypolipidemic Agents - Therapeutic Use
(123)
Female
(94)
Middle Aged
(91)
Adult
(65)
Cardiovascular System & Cardiology
(58)
Animals
(57)
Fenofibrate - Pharmacology
(51)
Biological And Medical Sciences
(49)
Medical Sciences
(49)
Aged
(46)
Triglycerides - Blood
(46)
Treatment Outcome
(43)
Lipids
(37)
Pharmacology & Pharmacy
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy

Fenofibrate improves renal lipotoxicity through activation of AMPK-PGC-1α in db/db mice

PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases

Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease

Fenofibrate monotherapy-induced rhabdomyolysis in a patient with post-pancreatitis diabetes mellitus: A rare case report and a review of the literature

Neuroprotective effects of peroxisome proliferator-activated receptor alpha and gamma agonists in model of parkinsonism induced by intranigral 1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine

Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study

Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice

Fenofibrate Increases the Population of Non-Classical Monocytes in Asymptomatic Chagas Disease Patients and Modulates Inflammatory Cytokines in PBMC

Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs

Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice

Effect of oleoylethanolamide on diet-induced nonalcoholic fatty liver in rats

PPAR-α agonist fenofibrate protects against the damaging effects of MPTP in a rat model of Parkinson's disease

Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients

Efficacy of fenofibrate for diabetic retinopathy: A systematic review protocol

Relationship of low molecular weight fluorophore levels with clinical factors and fenofibrate effects in adults with type 2 diabetes

Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study

Function and mechanism of the human SOD2 gene in mice cerebral ischemia/ reperfusion injury

Fenofibrate: a new treatment for diabetic retinopathy. Molecular mechanisms and future perspectives

Efficacy and safety of coenzyme A versus fenofibrate in patients with hyperlipidemia: a multicenter, double-blind, double-mimic, randomized clinical trial

Efficacy and safety of fenofibrate add-on therapy for patients with primary biliary cholangitis and a suboptimal response to UDCA

Fenofibrate attenuates renal lipotoxicity in uninephrectomized mice with high-fat diet-induced obesity

Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report

Fenofibrate lowers blood pressure in salt-sensitive but not salt-resistant hypertension

Health-related quality of life amongst people diagnosed with abdominal aortic aneurysm and peripheral artery disease and the effect of fenofibrate

Aktive Filter

Suchergebnisse filtern